Recurrent/Refractory Glioblastoma
1 clinical trials · Condition
◉ Watch Recurrent/Refractory Glioblastoma
| Record | Firm | Date |
|---|---|---|
| Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification (NCT02626364) | Arog Pharmaceuticals, Inc. | 2016-04-01 |
Track Recurrent/Refractory Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.